UK markets closed
Explore/

Biotech and drug stocks

Biotech and drug stocks

6.58k followers31 symbols Watchlist by Yahoo Finance

Follow this list to discover and track large drug and biotechnology companies.

Curated by Yahoo Finance

Follow this list to discover and track large drug and biotechnology companies. These companies develop speciality drugs and treatments for various diseases and medical conditions. Although there are risks associated with the success of the drug, those that succeed tend to have a strong series of earnings growth over a period of time, especially when they are backed by patents.

The list includes stocks priced at $5 or more with a three-month average daily trading volume in excess of 200,000 shares. This list is generated daily and sorted by market cap; the gains are based on the latest closing price and limited to the top 30 stocks that meet the criteria.

This watchlist is similar to a discontinued watchlist called ‘Battling Cancer’.

Background

Yahoo Finance employs sophisticated algorithms to monitor and detect trends in the global financial markets. We bring these insights to you in the form of watchlists.

Find other winning investment ideas with the Yahoo Finance Screener.

How are these weighted?

The stocks in this watchlist are weighted equally.

Performance

WatchlistChange today1-month return1-year returnTotal return
Biotech and drug stocks-0.81%---
^GSPC-1.51%-8.63%-16.62%+3755.51%

31 symbols

SymbolCompany nameLast priceChange% changeMarket timeVolumeAvg vol (3-month)Market cap
JNJJohnson & Johnson163.36-1.17-0.71%16:00 GMT-48.46M6.90M429.50B
LLYEli Lilly and Company323.35-6.66-2.02%16:03 GMT-44.21M2.73M307.24B
RHHBYRoche Holding AG40.62-0.49-1.19%16:00 GMT-41.99M1.46M272.58B
PFEPfizer Inc.43.76-0.40-0.91%16:03 GMT-421.64M17.66M245.60B
ABBVAbbVie Inc.134.21-8.51-5.96%16:03 GMT-414.91M5.51M237.30B
NVONovo Nordisk A/S99.63-0.76-0.76%16:00 GMT-41.09M1.68M225.39B
MRKMerck & Co., Inc.86.12-0.52-0.60%16:04 GMT-48.36M8.17M218.17B
NVSNovartis AG76.01-0.56-0.73%16:00 GMT-42.25M2.28M169.07B
AZNAstraZeneca PLC54.84-0.07-0.13%16:00 GMT-47.05M6.49M166.73B
BMYBristol-Myers Squibb Company71.09-0.62-0.86%16:00 GMT-410.80M9.68M151.80B
AMGNAmgen Inc.225.4-3.01-1.32%16:00 GMT-42.54M2.61M120.57B
SNYSanofi38.02+0.02+0.05%16:00 GMT-42.93M3.04M94.76B
GILDGilead Sciences, Inc.61.69-1.38-2.19%16:00 GMT-48.79M6.82M77.32B
REGNRegeneron Pharmaceuticals, Inc.688.87-2.95-0.43%16:00 GMT-4800.89k684.92k75.09B
VRTXVertex Pharmaceuticals Incorporated289.54-3.26-1.11%16:00 GMT-41.91M1.38M74.26B
ZTSZoetis Inc.148.29-2.66-1.76%16:04 GMT-42.31M1.68M69.42B
GSKGlaxoSmithKline plc29.43+0.07+0.24%16:00 GMT-46.63M6.87M57.98B
MRNAModerna, Inc.118.25+0.18+0.15%16:00 GMT-43.83M4.84M46.26B
BAYRYBayer Aktiengesellschaft11.56-0.16-1.37%15:59 GMT-4873.54k771.50k45.78B
TAKTakeda Pharmaceutical Company Limited12.97--16:00 GMT-42.86M2.46M40.32B
BIIBBiogen Inc.267+2.72+1.03%16:00 GMT-43.75M1.26M38.75B
BNTXBioNTech SE134.88+1.28+0.96%16:00 GMT-4735.18k892.85k32.73B
HLNHaleon plc6.09-0.02-0.33%16:00 GMT-44.49M9.27M28.02B
RPRXRoyalty Pharma plc40.18-0.15-0.37%16:00 GMT-41.40M1.82M27.16B
SGENSeattle Genetics, Inc.136.83+1.13+0.83%16:00 GMT-4676.80k1.07M25.24B
ALNYAlnylam Pharmaceuticals, Inc.200.16-9.23-4.41%16:00 GMT-41.68M1.04M24.02B
GMABGenmab A/S32.13+0.20+0.63%16:00 GMT-4773.25k606.36k20.85B
ARGXargenx SE353.05-4.50-1.26%16:00 GMT-4149.27k254.95k19.56B
BMRNBioMarin Pharmaceutical Inc.84.77-0.29-0.34%16:00 GMT-41.44M973.65k15.72B
INCYIncyte Corporation66.64+0.03+0.05%16:00 GMT-41.29M1.39M14.82B
  • Reuters

    Moderna refused China request to reveal vaccine technology - FT

    Moderna Inc has refused to hand over to China the core intellectual property behind the development of its COVID-19 vaccine, leading to a collapse in negotiations on its sale there, the Financial Times reported on Saturday, citing people familiar with the matter. The Cambridge, Massachusetts-based pharmaceutical company turned down China’s request to hand over the recipe for its mRNA vaccine because of commercial and safety concerns, the newspaper said, citing people involved in negotiations that took place between 2020 and 2021, adding that the vaccine maker is still “eager” to sell the product to China. The company had “given up” on its previous efforts to access the Chinese market because of China’s demand that it hand over the technology as a prerequisite for selling in the country, the report said.

  • Financial Times

    Moderna refused China request to reveal vaccine technology

    Moderna has refused to hand over to China the core intellectual property behind the development of its breakthrough Covid-19 vaccine, leading to a collapse in negotiations on its sale there, according to multiple people familiar with the matter. The Massachusetts-based pharmaceutical company turned down Beijing’s request to hand over the recipe for its messenger RNA vaccine because of commercial and safety concerns, said two people involved in negotiations that took place between 2020 and 2021. The vaccine maker says it is still “eager” to sell the product to China.

  • TheStreet.com

    How Far Will AbbVie's Humira Revenue Fall in 2023?

    The world's best-selling drug begins losing patent protections next year. AbbVie's revenue could take years to recover.